Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.u.s. License Agreement for Levocetirizine • March 16th, 2006 • Sepracor Inc /De/ • Pharmaceutical preparations
UCB S.A., having its registered office at Allée de la Recherche, 60, 1070 Brussels, Belgium, acting in its own name and on behalf of its AFFILIATES, hereinafter "UCB", on the one hand,
SEPRACOR INC. Executive Retention AgreementExecutive Retention Agreement • March 16th, 2006 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE RETENTION AGREEMENT by and between Sepracor Inc., a Delaware corporation (the "Company"), and Timothy J. Barberich (the "Executive") is made as of February 1, 2002 (the "Effective Date").
SEPRACOR INC. Executive Retention AgreementExecutive Retention Agreement • March 16th, 2006 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE RETENTION AGREEMENT by and between Sepracor Inc., a Delaware corporation (the "Company"), and (the "Executive") is made as of February 1, 2002 (the "Effective Date").
